| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 6 | +66.67% | +2.47% | +2.91% | -0.44% | -1.82% | — |
| 14d | 6 | +100.00% | +16.93% | +3.86% | +13.07% | +8.64% | — |
| 30d | 6 | +66.67% | +18.36% | -1.76% | +20.12% | +20.04% | — |
| 60d | 6 | +50.00% | +20.08% | +1.06% | +19.02% | +15.99% | — |
| 90d | 6 | +100.00% | +40.26% | +6.75% | +33.50% | +32.19% | — |
| 180d | 6 | +83.33% | +18.57% | +4.08% | +14.49% | +13.28% | — |
| 1y | 6 | +83.33% | +45.00% | +8.48% | +36.52% | +46.84% | — |
| 2y | 6 | +33.33% | +14.67% | +32.22% | -17.55% | -44.49% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| GANX GAIN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 15,000 | — | — | 15,000 | Jun 24, 2025 | Jun 25, 2025 ↗ | View → |
| GANX GAIN THERAPEUTICS, INC. | PURCHASE | 5,000 | $1.23 | $6.2K | 277,629 | Jul 1, 2024 | Jul 1, 2024 ↗ | View → |
| GANX GAIN THERAPEUTICS, INC. | PURCHASE | 12,000 | $1.21 | $14.5K | 289,629 | Jul 1, 2024 | Jul 1, 2024 ↗ | View → |
| GANX GAIN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 15,000 | — | — | 15,000 | Jun 24, 2024 | Jun 26, 2024 ↗ | View → |
| GANX GAIN THERAPEUTICS, INC. | PURCHASE | 54,900 | — | — | 272,629 | Sep 20, 2023 | Sep 22, 2023 ↗ | View → |
| GANX GAIN THERAPEUTICS, INC. | SALE | 54,900 | — | — | 0 | Sep 20, 2023 | Sep 22, 2023 ↗ | View → |
| GANX GAIN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 329,400 | — | — | 329,400 | Sep 20, 2022 | Sep 22, 2022 ↗ | View → |
| GANX GAIN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 54,900 | — | — | 54,900 | Sep 20, 2022 | Sep 22, 2022 ↗ | View → |
| GANX GAIN THERAPEUTICS, INC. | PURCHASE CHIEF EXECUTIVE OFFICER | 2,482 | $2.58 | $6.4K | 217,729 | May 25, 2022 | May 27, 2022 ↗ | View → |
| GANX GAIN THERAPEUTICS, INC. | PURCHASE CHIEF EXECUTIVE OFFICER | 9,256 | $2.83 | $26.2K | 215,247 | May 20, 2022 | May 23, 2022 ↗ | View → |
| GANX GAIN THERAPEUTICS, INC. | PURCHASE CHIEF EXECUTIVE OFFICER | 4,000 | $2.71 | $10.8K | 205,991 | May 19, 2022 | May 23, 2022 ↗ | View → |
| GANX GAIN THERAPEUTICS, INC. | PURCHASE Chief Executive Officer | 4,922 | $7.87 | $38.7K | 216,820 | Aug 16, 2021 | Apr 21, 2022 ↗ | View → |
| GANX GAIN THERAPEUTICS, INC. | PURCHASE | 4,922 | $7.87 | $38.7K | 216,820 | Aug 16, 2021 | Aug 17, 2021 ↗ | View → |
| ADMA ADMA BIOLOGICS, INC. | PURCHASEGRANT Stock grant | 15,000 | — | — | 15,000 | Feb 28, 2020 | Mar 3, 2020 ↗ | View → |
| ADMA ADMA BIOLOGICS, INC. | PURCHASEGRANT Stock grant | 7,500 | — | — | 44,030 | Feb 28, 2020 | Mar 3, 2020 ↗ | View → |